New Releases from NCBI BookshelfOdevixibat (Bylvay): Indication: For the treatment of cholestatic pruritus in patients aged 12 months and older with Alagille syndrome (ALGS): Reimbursement Recommendation [Internet].​Odevixibat (Bylvay): Indication: For the treatment of cholestatic pruritus in patients aged 12 months and older with Alagille syndrome (ALGS): Reimbursement Recommendation [Internet].